CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells.
about
C/EBPβ regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome-lysosome fusionLentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcomeGene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer.IκB-Kinase-epsilon (IKKε) over-expression promotes the growth of prostate cancer through the C/EBP-β dependent activation of IL-6 gene expression.
P2860
CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CCAAT/Enhancer binding protein ...... ence in prostate cancer cells.
@ast
CCAAT/Enhancer binding protein ...... ence in prostate cancer cells.
@en
type
label
CCAAT/Enhancer binding protein ...... ence in prostate cancer cells.
@ast
CCAAT/Enhancer binding protein ...... ence in prostate cancer cells.
@en
prefLabel
CCAAT/Enhancer binding protein ...... ence in prostate cancer cells.
@ast
CCAAT/Enhancer binding protein ...... ence in prostate cancer cells.
@en
P2093
P2860
P356
P1433
P1476
CCAAT/Enhancer binding protein ...... ence in prostate cancer cells.
@en
P2093
A D Friedman
I Paz-Priel
S R Denmeade
P2860
P2888
P304
P356
10.1038/ONC.2015.41
P407
P577
2015-03-16T00:00:00Z
P6179
1016805248